Irisin plasma concentration in PCOS and healthy subjects is related to body fat content and android fat distribution

被引:29
作者
Pukajlo, Katarzyna [1 ]
Laczmanski, Lukasz [1 ]
Kolackov, Katarzyna [1 ]
Kuliczkowska-Plaksej, Justyna [1 ]
Bolanowski, Marek [1 ]
Milewicz, Andrzej [1 ]
Daroszewski, Jacek [1 ]
机构
[1] Wroclaw Med Univ, Dept Endocrinol Diabet & Isotope Therapy, Wroclaw, Poland
关键词
Android obesity; Irisin; metabolic syndrome; polycystic ovary syndrome; POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CIRCULATING IRISIN; SEX-DIFFERENCES; NORMAL-WEIGHT; OBESITY; WOMEN; SERUM; FNDC5;
D O I
10.3109/09513590.2015.1065482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Irisin (Ir), a recently identified adipo-myokine, cleaved and secreted from the protein FNDC5 in response to physical activity, has been postulated to induce the differentiation of a subset of white adipocytes into brown fat and to mediate the beneficial effects on metabolic homeostasis. Metabolic syndrome (MS), a cluster of factors leading to impaired energy homeostasis, affects a significant proportion of subjects suffering from polycystic ovary syndrome (PCOS). The aim of our study was to investigate the relationship between Ir plasma concentrations and metabolic disturbances. The study group consisted of 179 PCOS patients and a population of 122 healthy controls (both groups aged 25-35 years). A subset of 90 subjects with MS was isolated. A positive association between Ir plasma level and MS in the whole group and in controls was found. In subjects with high adipose body content (>40%), Ir was higher than in lean persons (<30%). Our results showed a significant positive association between Ir concentration and android type of adipose tissue in the whole study group and in the control group. Understanding the role of Ir in increased energy expenditure may lead to the development of new therapeutics for obesity and obesity-related diseases.
引用
收藏
页码:907 / 911
页数:5
相关论文
共 32 条
  • [1] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti, K. G. M. M.
    Eckel, Robert H.
    Grundy, Scott M.
    Zimmet, Paul Z.
    Cleeman, James I.
    Donato, Karen A.
    Fruchart, Jean-Charles
    James, W. Philip T.
    Loria, Catherine M.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
  • [2] Bednarek-Tupikowska G, 2012, ENDOKRYNOL POL, V63, P447
  • [3] A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Bostroem, Pontus
    Wu, Jun
    Jedrychowski, Mark P.
    Korde, Anisha
    Ye, Li
    Lo, James C.
    Rasbach, Kyle A.
    Bostroem, Elisabeth Almer
    Choi, Jang Hyun
    Long, Jonathan Z.
    Kajimura, Shingo
    Zingaretti, Maria Cristina
    Vind, Birgitte F.
    Tu, Hua
    Cinti, Saverio
    Hojlund, Kurt
    Gygi, Steven P.
    Spiegelman, Bruce M.
    [J]. NATURE, 2012, 481 (7382) : 463 - U72
  • [4] Circulating Irisin and Glucose-Dependent Insulinotropic Peptide Are Associated With the Development of Polycystic Ovary Syndrome
    Chang, Chia Lin
    Huang, Shang Yu
    Soong, Yung Kuei
    Cheng, Po Jen
    Wang, Chin-Jung
    Liang, I. Ting
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12) : E2539 - E2548
  • [5] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [6] Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome
    Chen, Chin-I
    Hsu, Ming-I
    Lin, Shyh-Hsiang
    Chang, Yuan-Chin I.
    Hsu, Chun-Sen
    Tzeng, Chii-Ruey
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (04) : 264 - 268
  • [7] Serum irisin levels in new-onset type 2 diabetes
    Choi, Yeon-Kyung
    Kim, Mi-Kyung
    Bae, Kwi Hyun
    Seo, Hyun-Ae
    Jeong, Ji-Yun
    Lee, Won-Kee
    Kim, Jung-Guk
    Lee, In-Kyu
    Park, Keun-Gyu
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (01) : 96 - 101
  • [8] Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
    Diamanti-Kandarakis, Evanthia
    Dunaif, Andrea
    [J]. ENDOCRINE REVIEWS, 2012, 33 (06) : 981 - 1030
  • [9] Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
    Dunaif, A
    [J]. ENDOCRINE REVIEWS, 1997, 18 (06) : 774 - 800
  • [10] Obesity and the polycystic ovary syndrome
    Gambineri, A
    Pelusi, C
    Vicennati, V
    Pagotto, U
    Pasquali, R
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (07) : 883 - 896